Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, South Africa; Department of Physiology and Anatomy, Faculty of Medicine, National University of Science and Technology, Box AC939, Ascot, Bulawayo, Zimbabwe.
School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, 2193 Johannesburg, South Africa.
Brain Behav Immun. 2018 Feb;68:211-223. doi: 10.1016/j.bbi.2017.10.019. Epub 2017 Oct 23.
Brewer's yeast, derived from the yeast species Saccharomyces cerevisiae (S. cerevisiae), is commonly used for inducing pyrexia in pharmacological studies screening antipyretics in rats. Despite its widespread use, the peripheral and central inflammatory response associated with Brewer's yeast-induced fever and sickness behavior in rats has not been investigated. Thus, we injected male Sprague-Dawley rats (150-200 g) subcutaneously with a high (4 g/kg, n = 9), medium (2 g/kg, n = 5) or low (0.4 g/kg, n = 6) dose of Brewer's yeast solution or saline (0.9%, n = 6) and measured core body temperature, cage activity, food intake and body mass for six days after injection. Blood and brain samples were collected at 2, 8, 18 and 72 h after injection; n = 5-7 per time point. Brewer's yeast administration dose-dependently induced fever, lethargy, anorexia and body mass stunting that was accompanied by increased blood plasma levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α and activation of inflammatory transcription factors (nuclear factor (NF) for interleukin-6, signal transducer and activator of transcription (STAT)-3, and NF-κB)) in the hypothalamus and circumventricular organs. The increased activation of transcription factors following Brewer's yeast administration was accompanied by increased hypothalamic mRNA expression of TNF-α, IL-1β and IL-6 and rate-limiting enzymes for prostaglandin synthesis. Our results show that subcutaneous administration of S. cerevisae induces prolonged fever, anorexia and lethargy that is accompanied by a pronounced increase in the synthesis of pro-inflammatory cytokines, key prostaglandin synthesizing enzymes and transcription factors, in the periphery and brain.
啤酒酵母,来源于酿酒酵母(Saccharomyces cerevisiae),常用于诱导药理学研究中大鼠的发热,以筛选解热药。尽管其应用广泛,但尚未研究啤酒酵母诱导发热和大鼠疾病行为相关的外周和中枢炎症反应。因此,我们给雄性 Sprague-Dawley 大鼠(150-200g)皮下注射高(4g/kg,n=9)、中(2g/kg,n=5)或低(0.4g/kg,n=6)剂量的啤酒酵母溶液或生理盐水(0.9%,n=6),并在注射后六天测量核心体温、笼内活动、食物摄入和体重。在注射后 2、8、18 和 72 小时采集血液和脑组织样本;每个时间点 n=5-7。啤酒酵母给药剂量依赖性地诱导发热、昏睡、厌食和体重下降,同时伴有血浆白细胞介素(IL)-6 和肿瘤坏死因子(TNF)-α水平升高以及下丘脑和室周器官中炎症转录因子(核因子(NF)-白细胞介素 6、信号转导和转录激活因子(STAT)-3 和 NF-κB)激活增加。啤酒酵母给药后转录因子的激活增加伴随着下丘脑 TNF-α、IL-1β 和 IL-6 以及前列腺素合成限速酶的 mRNA 表达增加。我们的结果表明,酿酒酵母的皮下给药会导致长时间发热、厌食和昏睡,同时外周和大脑中促炎细胞因子、关键前列腺素合成酶和转录因子的合成显著增加。